AstraZeneca could buy Actelion: Citi


AstraZeneca (AZN) may be interested in buying Actelion (ALIOF), Citi says, in a note that sent shares of the Swiss biotech surging in overseas trade.

Here's the actual quote (via Reuters): "Creative corporate finance
... coupled with 'long runway' acquisitions such as Actelion could provide a useful bridge to organically fueled growth."

Citi thinks the deal would boost operating profits by double-digits for AZN.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs